Primary Job Title CEO and President Primary Organization GeneCentric Therapeutics
Location Apex, North Carolina, United States Regions Research Triangle, East Coast, Southern US Gender Male
LinkedIn View on LinkedIn
Dr. Milburn received his Ph.D. in Biophysical Chemistry at the University of California, Berkeley and was a research fellow at Harvard Medical School for his post-doctoral work. Before joining Metabolon, Dr. Milburn was Senior Vice President of Research and Corporate Development at Sirtris Pharmaceuticals where he led the preclinical/clinical
development of drugs in metabolic disease and neurodegeneration. Prior to Sirtris, Dr. Milburn was Senior Vice President of Research at Plexxikon and was responsible for the development of Plexxikon's proprietary high-throughput scaffold-based chemical technology platform.Since 2005, Dr. Milburn has been Chief Scientific Officer at Metabolon and has been responsible for the global metabolomics technology development and research operations. Dr. Milburn’s R&D group works with over 600 clients at Metabolon and has completed over 3000 commercial studies since 2005. Metabolon’s research group has published over 300 peer-reviewed articles with many of Metabolon’s clients.
